Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

Trial Profile

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Mar 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Iron sucrose (Primary)
  • Indications Iron deficiency anaemia
  • Focus Therapeutic Use
  • Acronyms Iron-RANC

Most Recent Events

  • 11 Mar 2025 Planned End Date changed from 1 Feb 2026 to 1 Feb 2027.
  • 11 Mar 2025 Planned primary completion date changed from 1 Feb 2025 to 1 Feb 2026.
  • 10 Apr 2023 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top